基本信息
浏览量:1011
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Analysis of clinical trials with correlative laboratory data
Analysis of laboratory and animal data
There exists a substantial statistical literature exists on the design and analysis of clinical trials with response or time-to-event end points. However, early-stage trials with biologic end points, such as vaccine studies or investigations of targeted therapies, require alternative approaches. It is crucial that in the planning stage, the unique aspects of a biologic or molecular therapy be taken into account. This principle extends to the design of laboratory studies, and especially to those correlative laboratory studies that embedded in clinical investigations.
An aspect of the complexity of laboratory studies—whether in basic science, animals, or humans--is the abundance of data. With the advent of whole genome or whole exome sequencing in conjunction with epigenetic or proteomic studies on the same patient, the number of laboratory values collected far exceeds the number of patients. Dr. Neuberg's current interests concern the planning and analysis of studies that integrate laboratory outcomes at the genome, transcriptome, or proteome level with clinical and demographic information.
Analysis of laboratory and animal data
There exists a substantial statistical literature exists on the design and analysis of clinical trials with response or time-to-event end points. However, early-stage trials with biologic end points, such as vaccine studies or investigations of targeted therapies, require alternative approaches. It is crucial that in the planning stage, the unique aspects of a biologic or molecular therapy be taken into account. This principle extends to the design of laboratory studies, and especially to those correlative laboratory studies that embedded in clinical investigations.
An aspect of the complexity of laboratory studies—whether in basic science, animals, or humans--is the abundance of data. With the advent of whole genome or whole exome sequencing in conjunction with epigenetic or proteomic studies on the same patient, the number of laboratory values collected far exceeds the number of patients. Dr. Neuberg's current interests concern the planning and analysis of studies that integrate laboratory outcomes at the genome, transcriptome, or proteome level with clinical and demographic information.
研究兴趣
论文共 1343 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Gregory H Bird,J J Patten,William Zavadoski,Nicole Barucci,Marina Godes, Benjamin M Moyer, Callum D Owen,Paul DaSilva-Jardine,Donna S Neuberg,Richard A Bowen,Robert A Davey,Loren D Walensky
Nature communicationsno. 1 (2024): 274-274
Genes & developmentno. 5-6 (2024): 289-289
Qingyu Luo, Evangeline G Raulston,Miguel A Prado,Xiaowei Wu,Kira Gritsman, Karley S Whalen,Kezhi Yan,Christopher A G Booth,Ran Xu,Peter van Galen,John G Doench,Shai Shimony,
Natureno. 8015 (2024): 198-205
Leukemiano. 7 (2024): 1-7
bioRxiv the preprint server for biology (2024)
Leukemiano. 4 (2024): 1-7
Blood Advances (2024)
Yang C. Zeng, Olivia J. Young,Christopher M. Wintersinger,Frances M. Anastassacos,James I. MacDonald, Giorgia Isinelli,Maxence O. Dellacherie,Miguel Sobral,Haiqing Bai,Amanda R. Graveline,Andyna Vernet, Melinda Sanchez,
GENES & DEVELOPMENTno. 5-6 (2024): 289-289
Bone Marrow Transplantationno. 5 (2024): 1-8
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn